Literature DB >> 12049705

[Antimicrobial use in Spanish hospitals (EPINE, 1990-1999)].

Angel Asensio1, Rafael Cantón, Josep Vaqué, José Rosselló, José Luis Arribas.   

Abstract

BACKGROUND: Monitoring of antimicrobial use and knowledge of prescription habits are some of the strategies recommended to contain the resistance to antimicrobials in hospitals.
METHOD: We analyzed a series of 10 annual studies of prevalence during the period 1990-1999 (EPINE project) in Spanish hospitals. Estimates of antimicrobial use were calculated as the percent distribution of every antimicrobial related to the overall antimicrobials prescribed.
RESULTS: Among 484,013 hospitalized patients, 34 to 36% were receiving antimicrobials (antibiotics > 90%). Amoxicillin-clavulanate use increased from 3.8% in 1990 up to 14.8% in 1999 (P < 0.01). Significant increases were also observed in the use of carbapenems (0.9 to 2.7%; P < 0.01), glycopeptides (1.7 to 3.7%; P < 0.01) and quinolones (8.5 to 11.3%; P < 0.01) though to a lesser degree. Conversely, the use of aminoglycosides decreased over the decade studied (15.8 to 9.4%; P < 0.01).
CONCLUSIONS: Even though the use of antimicrobials has increased over the last decade, current figures are within the ranges observed in other countries. The pattern of antibiotics use has changed during this period: while the use of aminoglycosides decreased, that of -lactams plus -lactamase inhibitors, quinolones and carbapenems increased.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12049705     DOI: 10.1016/s0025-7753(02)72514-1

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  1 in total

1.  Clonal dissemination of Yersinia enterocolitica strains with various susceptibilities to nalidixic acid.

Authors:  Javier Sánchez-Céspedes; Margarita M Navia; Rocío Martínez; Beatriz Orden; Rosario Millán; Joaquín Ruiz; Jordi Vila
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.